Copyright
©The Author(s) 2024.
World J Hepatol. Aug 27, 2024; 16(8): 1167-1176
Published online Aug 27, 2024. doi: 10.4254/wjh.v16.i8.1167
Published online Aug 27, 2024. doi: 10.4254/wjh.v16.i8.1167
Table 3 Magnetic resonance imaging and albumin/bilirubin in control and experimental groups
Parameters | Control group (n = 10) | Experimental group (n = 13) | P value |
T1pre (millisecond) | 659.13 ± 24.07 | 681.57 ± 40.58 | 0.137 |
T1post (millisecond) | 408.87 ± 27.21 | 120.48 ± 53.71 | < 0.001 |
△T1% | 37.84 ± 5.46 | 82.40 ± 7.62 | < 0.001 |
ESP | 4.14 ± 0.95 | 19.67 ± 12.12 | < 0.001 |
ALBI | 0.95 ± 0.04 | 0.12 ± 0.89 | < 0.001 |
- Citation: Chen YY, Yang L, Li J, Rao SX, Ding Y, Zeng MS. Gadoxetic acid-enhanced magnetic resonance imaging in the assessment of hepatic sinusoidal obstruction syndrome in a mouse model. World J Hepatol 2024; 16(8): 1167-1176
- URL: https://www.wjgnet.com/1948-5182/full/v16/i8/1167.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i8.1167